The main objective of this review is to summarise, for primary and secondary care doctors, the management options and current supporting evidence for clinically localised prostate cancer.
We review all aspects of management including current guidelines on early cancer detection and the importance of informed consent on PSA-based screening and assess the most common treatment options and the evidence for managing patients with low-, medium-, and high-risk disease.
Pini G, Collins J, Ghadjar P, Wiklund P. Are you the author?
Karolinska Institute, Department of Molecular Medicine and Surgery, Section of Urology, Solna, Stockholm, Sweden.
Reference: Curr Urol Rep. 2015 May;16(5):502.